Analyzing immune responses of hematological cancers could inform immunotherapy options

Written by Caitlin Killen, Future Science group

A multi-institute team including researchers from the University of Eastern Finland, the University of Helsinki and Helsinki University Hospital (all Finland) have utilized a dataset comprising over 10,000 patients to characterize the immune landscape of hematological cancers. It is hoped the work – published this week in Cancer Cell – could be used to identify effective immunotherapies and stratify patients who are more likely to respond to immunotherapy. Immunotherapy has shown particular promise for the treatment of solid tumors; however, its potential in hematological malignancies is yet to be fully realized. Immunotherapy works by activating the immune system in an...

To view this content, please register now for access

It's completely free